Akèy › Kolit Ulseratif › Rhode Island › Providence
Etid klinik pou Kolit Ulseratif nan Providence, RI
11 etid pou Kolit Ulseratif ap chèche patisipan nan sit nan ak bò kote Providence (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Ap rekriteFaz 4
- University Gastroenterology, Providence
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Ap rekriteFaz 2
- Site 025, Providence
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Ap rekriteFaz 2
- Site US-019, Providence
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Ap rekriteFaz 2
- University Gastroenterology - Providence - Staniford Street /ID# 280919, Providence
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Ap rekriteFaz 3
- University Gastroenterology, Providence
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Ap rekriteFaz 3
- University Gastroenterology, Providence
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Ap rekriteFaz 2
- University Gastroenterology - Providence - West River Street, Providence
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Ap rekriteFaz 4
- University Gastroenterology, Providence
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Ap rekriteFaz 3
- University Gastroenterology - GI Alliance - Site Number: 8400103, Providence
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Ap rekrite
- Gastroenterology Associates, Providence
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Ap rekriteFaz 2
- Mirador Therapeutics Selected Site, Providence
Etid Kolit Ulseratif nan lòt vil
- New York City, NY24 etid
- Orlando, FL23 etid
- Miami, FL22 etid
- Houston, TX18 etid
- San Antonio, TX16 etid
- San Diego, CA16 etid
- Tacoma, WA15 etid
- Chicago, IL15 etid
- Colorado Springs, CO14 etid
- St. Louis, MO14 etid
- Tyler, TX14 etid
- Los Angeles, CA13 etid
Lòt etid nan Providence
- Kansè Endomèt15 etid
- Kansè ovè15 etid
- Obèsite14 etid
- Kansè (tout kalite)13 etid
- Maladi Crohn12 etid
- Kansè Poumon ki pa ti selil12 etid
- Kansè nan tete11 etid
- Leksemi mieloïd egi10 etid
- Sipwa9 etid
- Kansè Metastatik9 etid
- Twoub Konsomasyon Alkòl (AUD)8 etid
- Maladi Alzheimer8 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.